Light chain amyloidosis: the heart of the problem von Merlini, Giampaolo, Palladini, Giovanni

Volltext

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis von Comenzo, R L, Reece, D, Palladini, G, Seldin, D, Sanchorawala, V, Landau, H, Falk, R, Wells, K, Solomon, A, Wechalekar, A, Zonder, J, Dispenzieri, A, Gertz, M, Streicher, H, Skinner, M, Kyle, R A, Merlini, G

Volltext

AA amyloidosis: basic knowledge, unmet needs and future treatments von Obici, Laura, Merlini, Giampaolo

Volltext

AL Amyloidosis von Merlini, G

Volltext

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis von Merlini, G, Lousada, I, Ando, Y, Dispenzieri, A, Gertz, M A, Grogan, M, Maurer, M S, Sanchorawala, V, Wechalekar, A, Palladini, G, Comenzo, R L

Volltext

The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies von Merlini, G, Westermark, P

Volltext

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients von Palladini, G, Milani, P, Foli, A, Vidus Rosin, M, Basset, M, Lavatelli, F, Nuvolone, M, Obici, L, Perlini, S, Merlini, G

Volltext

Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial... von Brannagan, T. H., Wang, A. K., Coelho, T., Waddington Cruz, M., Polydefkis, M. J., Dyck, P. J., Plante‐Bordeneuve, V., Berk, J. L., Barroso, F., Merlini, G., Conceição, I., Hughes, S. G., Kwoh, J., Jung, S. W., Guthrie, S., Pollock, M., Benson, M. D., Gertz, M., Drachman, Brian, Gorevic, Peter, Heitner, Stephen, Scheinberg, Morton, Schmidt, Hartmut, Whelan, Carol, Adams, David, Campistol Plana, Josep Maria, Gamez, Josep, Gane, Edward, Kristen, Arnt, Obici, Laura, Salvi, Fabrizio, Souza Bulle Oliveira, Acary, Vita, Giuseppe

Volltext

Amyloidosis: is a cure possible? von Merlini, G., Palladini, G.

Volltext

International uniform response criteria for multiple myeloma von Durie, B G M, Harousseau, J-L, Miguel, J S, Bladé, J, Barlogie, B, Anderson, K, Gertz, M, Dimopoulos, M, Westin, J, Sonneveld, P, Ludwig, H, Gahrton, G, Beksac, M, Crowley, J, Belch, A, Boccadaro, M, Turesson, I, Joshua, D, Vesole, D, Kyle, R, Alexanian, R, Tricot, G, Attal, M, Merlini, G, Powles, R, Richardson, P, Shimizu, K, Tosi, P, Morgan, G, Rajkumar, S V

Volltext

Management of treatment-emergent peripheral neuropathy in multiple myeloma von Richardson, P G, Delforge, M, Beksac, M, Wen, P, Jongen, J L, Sezer, O, Terpos, E, Munshi, N, Palumbo, A, Rajkumar, S V, Harousseau, J L, Moreau, P, Avet-Loiseau, H, Lee, J H, Cavo, M, Merlini, G, Voorhees, P, Chng, W J, Mazumder, A, Usmani, S, Einsele, H, Comenzo, R, Orlowski, R, Vesole, D, Lahuerta, J J, Niesvizky, R, Siegel, D, Mateos, M-V, Dimopoulos, M, Lonial, S, Jagannath, S, Bladé, J, Miguel, J San, Morgan, G, Anderson, K C, Durie, B G M, Sonneveld, P

Volltext

Bortezomib in the treatment of AL amyloidosis: targeted therapy? von Sitia, Roberto, Palladini, Giovanni, Merlini, Giampaolo

Volltext

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel von Caers, J, Paiva, B, Zamagni, E, Leleu, X, Bladé, J, Kristinsson, S Y, Touzeau, C, Abildgaard, N, Terpos, E, Heusschen, R, Ocio, E, Delforge, M, Sezer, O, Beksac, M, Ludwig, H, Merlini, G, Moreau, P, Zweegman, S, Engelhardt, M, Rosiñol, L

Volltext

What is new in diagnosis and management of light chain amyloidosis? von Palladini, Giovanni, Merlini, Giampaolo

Volltext

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma von da Silva Filho, M I, Försti, A, Weinhold, N, Meziane, I, Campo, C, Huhn, S, Nickel, J, Hoffmann, P, Nöthen, M M, Jöckel, K-H, Landi, S, Mitchell, J S, Johnson, D, Morgan, G J, Houlston, R, Goldschmidt, H, Jauch, A, Milani, P, Merlini, G, Rowcieno, D, Hawkins, P, Hegenbart, U, Palladini, G, Wechalekar, A, Schönland, S O, Hemminki, K

Volltext

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL) von Palladini, Giovanni, Perfetti, Vittorio, Perlini, Stefano, Obici, Laura, Lavatelli, Francesca, Caccialanza, Riccardo, Invernizzi, Rosangela, Comotti, Benedetto, Merlini, Giampaolo

Volltext

Systemic amyloidosis: novel therapies and role of biomarkers von Nuvolone, Mario, Merlini, Giampaolo

Volltext

A revised international prognostic score system for Waldenström’s macroglobulinemia von Gavriatopoulou, M., Kastritis, E., Morel, P., Duhamel, A., Kyrtsonis, M.C., Durot, E., Symeonidis, A., Laribi, K., Hatjiharisi, E., Ysebaert, L., Vassou, A., Giannakoulas, N., Merlini, G., Repousis, P., Varettoni, M., Michalis, E., Hivert, B., Michalis, M., Leblond, V., Dimopoulos, M.A.C.

Volltext

P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES von Gertz, M., Cohen, A., Comenzo, R., Kastritis, E., Landau, H., Libby, E., Liedtke, M., Sanchorawala, V., Schönland, S., Wechalekar, A., Ando, Y., Koh, Y., Zonder, J., Palladini, G., Nie, C., Karp, C., Jin, Y., Conrad, A., Kinney, G., Merlini, G.

Volltext

P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK von Kastritis, E., Palladini, G., Dimopoulos, M. A., Jaccard, A., Merlini, G., Theodorakakou, F., Fotiou, D., Minnema, M. C., Wechalekar, A., Gkolfinopoulos, S., Manousou, K., Sonneveld, P., Schönland, S.

Volltext